AllianceBernstein
ADVM

AllianceBernstein’s Adverum Biotechnologies ADVM Stock Holding History

AllianceBernstein’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-10,210
Closed -$134K – 3258
2022
Q1 		$134K Buy
10,210
+40
+0.4% +$585 ﹤0.01% 3077
2021
Q4 		$179K Sell
10,170
-1,060
-9% -$21.2K ﹤0.01% 3099
2021
Q3 		$244K Sell
11,230
-1,120
-9% -$28.6K ﹤0.01% 3026
2021
Q2 		$432K Buy
12,350
+2,320
+23% +$125K ﹤0.01% 2875
2021
Q1 		$989K Hold
10,030
– – ﹤0.01% 2417
2020
Q4 		$1.09M Hold
10,030
– – ﹤0.01% 2258
2020
Q3 		$1.03M Sell
10,030
-210
-2% -$31.4K ﹤0.01% 2171
2020
Q2 		$2.14M Buy
10,240
+3,650
+55% +$646K ﹤0.01% 1807
2020
Q1 		$644K Buy
6,590
+1,180
+22% +$138K ﹤0.01% 2230
2019
Q4 		$623K Hold
5,410
– – ﹤0.01% 2457
2019
Q3 		$295K Hold
5,410
– – ﹤0.01% 2809
2019
Q2 		$643K Buy
5,410
+3,380
+167% +$280K ﹤0.01% 2501
2019
Q1 		$106K Buy
2,030
+310
+18% +$12.5K ﹤0.01% 3006
2018
Q4 		$54K Hold
1,720
– – ﹤0.01% 3051
2018
Q3 		$104K Buy
1,720
+640
+59% +$35.9K ﹤0.01% 3075
2018
Q2 		$57K Buy
+1,080
New +$64.9K ﹤0.01% 3087
2017
Q2 		– Sell
-2,430
Closed -$66K – 3146
2017
Q1 		$66K Hold
2,430
– – ﹤0.01% 2956
2016
Q4 		$70K Hold
2,430
– – ﹤0.01% 2984
2016
Q3 		$100K Sell
2,430
-190
-7% -$7.21K ﹤0.01% 2930
2016
Q2 		$83K Buy
2,620
+380
+17% +$17.2K ﹤0.01% 2929
2016
Q1 		$116K Hold
2,240
– – ﹤0.01% 2804
2015
Q4 		$213K Sell
2,240
-253
-10% -$22.2K ﹤0.01% 2728
2015
Q3 		$205K Sell
2,493
-7
-0.3% -$894 ﹤0.01% 2771
2015
Q2 		$406K Buy
2,500
+1,460
+140% +$493K ﹤0.01% 2660
2015
Q1 		$421K Buy
1,040
+780
+300% +$330K ﹤0.01% 2555
2014
Q4 		$140K Buy
+260
New +$100K ﹤0.01% 2905

Other funds holding ADVM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SFI
Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

AllianceBernstein's ADVM Position: Q2 2022 in Review

AllianceBernstein sold out of Adverum Biotechnologies (ADVM) in Q2 2022, closing a stake of 10,210 shares — an estimated $134K sold.

AllianceBernstein first reported a position in ADVM in Q4 2014 and held it in 26 quarters. The position peaked at $2.14M in Q2 2020. 77 funds tracked by Wall St. Rank hold ADVM as of Q2 2022.

  • AllianceBernstein reported no remaining Adverum Biotechnologies position as of Q2 2022 after selling out during the quarter.
  • AllianceBernstein sold 10,210 Adverum Biotechnologies shares in Q2 2022, an estimated $134K.
  • AllianceBernstein first reported a position in Adverum Biotechnologies in Q4 2014 and held it in 26 quarters.
  • AllianceBernstein's Adverum Biotechnologies position peaked at $2.14M in Q2 2020.
  • 77 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q2 2022.

Based on AllianceBernstein's 13F filing for Q2 2022, filed 15 Aug 2022.